Medifast, Inc. (0K05.L)

USD 18.48

(-0.75%)

EBITDA Summary of Medifast, Inc.

  • Medifast, Inc.'s latest annual EBITDA in 2023 was 139.5 Million USD , down -28.74% from previous year.
  • Medifast, Inc.'s latest quarterly EBITDA in 2024 Q1 was 12.3 Million USD , down -33.99% from previous quarter.
  • Medifast, Inc. reported an annual EBITDA of 201.83 Million USD in 2022, down -12.22% from previous year.
  • Medifast, Inc. reported an annual EBITDA of 223.05 Million USD in 2021, up 66.26% from previous year.
  • Medifast, Inc. reported a quarterly EBITDA of -4.8 Million USD for 2024 Q2, down -160.57% from previous quarter.
  • Medifast, Inc. reported a quarterly EBITDA of 12.3 Million USD for 2024 Q1, down -33.99% from previous quarter.

Annual EBITDA Chart of Medifast, Inc. (2023 - 1996)

Historical Annual EBITDA of Medifast, Inc. (2023 - 1996)

Year EBITDA EBITDA Growth
2023 139.5 Million USD -28.74%
2022 201.83 Million USD -12.22%
2021 223.05 Million USD 66.26%
2020 134.15 Million USD 47.36%
2019 95.66 Million USD 31.82%
2018 73.49 Million USD 74.26%
2017 43.84 Million USD 47.56%
2016 32.26 Million USD -6.36%
2015 37.88 Million USD -5.16%
2014 38.29 Million USD -32.74%
2013 44.97 Million USD 93.33%
2012 23.26 Million USD -35.65%
2011 35.72 Million USD 112771.19%
2010 37.49 Million USD -99.84%
2009 24.7 Million USD 50.71%
2008 12.79 Million USD 42.19%
2007 9.18 Million USD -14.01%
2006 10.5 Million USD 81.98%
2005 5.81 Million USD 34.23%
2004 4.46 Million USD 3.75%
2003 4.24 Million USD 105.58%
2002 2.07 Million USD 126.37%
2001 956 Thousand USD 33.38%
2000 704 Thousand USD 130.89%
1999 -1.83 Million USD -324.22%
1998 -340 Thousand USD 77.57%
1997 -2.26 Million USD -311.19%
1996 1.1 Million USD 0.0%

Peer EBITDA Comparison of Medifast, Inc.

Name EBITDA EBITDA Difference
H&R Block, Inc. 963.18 Million USD 85.516%